Data protection Impressum

Healthcare

The Lausanne University Hospital (CHUV) strengthens its oncology network with the launch of a dedicated bladder cancer center offering personalized, high-level treatment and coordinated support.

CHUV opens new bladder cancer center combining advanced care and interdisciplinary expertise

16 June 2025

In this episode of Getting Serious with Woody Wade, we sit down with André Hoffmann, Vice Chairman of Roche and a leading voice in sustainable business, to explore how companies, both large and small, can become forces for long-term prosperity and ecological regeneration.

How Business Can Regenerate the Planet (A Conversation with André Hoffmann)

16 June 2025

At the crossroads of tradition and innovation, the University of Fribourg’s Section of Medicine offers a distinct vision for the future of healthcare. As part of Switzerland’s only fully bilingual university, the Section of Medicine is advancing both education and translational research in a collaborative, human-focused environment.

The University of Fribourg’s human-centered approach to medicine

Start-ups Aseptuva, Bloom Biorenewables, and Hafnova have been selected for multi-year EU-funded projects, reinforcing Western Switzerland’s importance in health tech, sustainable chemistry and cybersecurity.

Three rising Western Switzerland start-ups join major European innovation programs

3 June 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (May 2025)

28 May 2025

Western Switzerland is rapidly becoming a hotspot for biomanufacturing and life sciences companies, thanks to its strong infrastructure, skilled talent, and business-friendly policies. Yassin Nahi, GGBa (Greater Geneva Bern area) Life Science Director, shares how the region's research hubs, academic institutions, and regulatory support make it an ideal location for companies in this sector.

Why Switzerland

Why Western Switzerland for Biomanufacturing and Life Sciences Companies: an interview with expert Yassin Nahi

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

Bern-based medtech LEM Surgical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Dynamis Robotic Surgical System. The announcement marks a major regulatory milestone for the company and paves the way for the introduction of its next-generation spine surgery robot into U.S. hospitals.

LEM Surgical receives FDA clearance for its Dynamis Robotic Surgical System

26 May 2025

Lausanne-based biotech ReproNovo has secured USD 65 million to advance Phase 2 trials for novel therapies in male infertility and women’s reproductive health.

ReproNovo raises USD 65 million to advance trials in reproductive health

21 May 2025

1 2 3 4 5 … 18